Inducible phosphofructokinase and the Warburg effect
AssigneeThe Picower Institute for Medical Research
InventorsRichard J. Bucala, Jason A. Chesney, Robert A. Mitchell
Life of this patent
Estimating the term…
Abstract
There is disclosed a cancer malignancy diagnostic assay comprising obtaining a sample of a body fluid or tissue, performing a sequence identity assay to look for the presence of iPFK-2 specific sequences; an anticancer pharmaceutical composition comprising a specific antisense oligonucleotide to the inventive isolated iPFK-2 sequence and a pharmaceutically acceptable oligonucleotide carrier; and a method for finding therapeutically active anti-cancer compounds comprising screening compounds for activity to inhibit iPFK-2, preferably kinase activity.
Claims1
An isolated antibody that binds to an epitope of the inducible human phosphofructokinase-2 (iPFK-2) isozyme wherein said epitope comprises the amino acids of SEQ ID NO.:24.
Dependencies are inferred from the claim text.